Evolent Health Inc Class A (EVH)

Over the past six months, Evolent Health's stock price has experienced significant fluctuations. Recent events include the Q1 2026 earnings announcement where the EPS loss beat expectations but revenue was missed, and the Q4 2025 earnings announcement which led to a stock price increase. Analyst rating adjustments occurred in November 2025, with lowered price targets. In March 2026, Archie Mayani was appointed as chief product officer. Evolent divested its value-based primary care business to Privia Health Group, Inc.

While specific seasonality for Evolent Health's products and services is not extensively outlined, the healthcare sector generally experiences seasonal fluctuations in demand. Evolent Health's revenues can be influenced by enrollment cycles and seasonal patterns within health plans. The company's solutions are likely to see consistent demand given the ongoing challenges of rising medical costs and the shift towards value-based care.

Evolent Health, Inc. is a healthcare company providing technology-enabled clinical and administrative solutions to payers and providers in the United States. Founded in 2011, it operates in the Healthcare sector, focusing on value-based care and population health management. The company delivers services through Evolent Health Services and Clinical Solutions, including specialty care management and an integrated value-based care platform. Key products include Identifi and Machinify Auth Intelligence, aiming to improve health, simplify healthcare, and make it more affordable.

Evolent Health, Inc. is headquartered in Arlington, Virginia, and has a significant presence across the United States, with approximately 30 office locations in various states and cities.

Evolent Health has a reputation as a key player in the healthcare information services industry, known for innovative solutions and is recognized as a top place to work in healthcare nationally. The company focuses on improving healthcare delivery and patient outcomes, particularly for individuals with complex conditions, emphasizing a provider-centric approach and patient well-being. Evolent highlights its strong data privacy and security, with compliance and certifications such as SOC 2 and HITRUST CSF® Certification.

Evolent Health, Inc. has a diverse ownership structure, with institutional investors holding a significant portion of the company's shares. Major institutional owners include BlackRock, Inc., Morgan Stanley, and Vanguard Group Inc. Retail investors also hold a significant portion, with approximately 68.33% of the stock held by public companies and individual investors. Insiders hold approximately 2.13% of the company's stock.